Clinical Trial Update: Use of Pentoxifylline in Human T-lymphotropic Virus Type-1 (HTLV-1) Diseases [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating pentoxifylline for HTLV-1–related diseases, including Tropical Spastic Paraparesis, has completed; results are not provided in the avai…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Htlv-1 Infection
• Tropical Spastic Paraparesis

Drugs mentioned

• Pentoxifylline (pentoxifylline)

Snippet

Sponsor: Hospital Universitário Professor Edgard Santos | Conditions: HTLV-1, Tropical Spastic Paraparesis | Phase 3 | Status: COMPLETED